125 related articles for article (PubMed ID: 16981907)
1. A functional polymorphism of apolipoprotein C1 detected by mass spectrometry.
Wroblewski MS; Wilson-Grady JT; Martinez MB; Kasthuri RS; McMillan KR; Flood-Urdangarin C; Nelsestuen GL
FEBS J; 2006 Oct; 273(20):4707-15. PubMed ID: 16981907
[TBL] [Abstract][Full Text] [Related]
2. Correlation of a T45S variant of apolipoprotein C1 with elevated BMI in persons of American Indian and Mexican ancestries.
Kasthuri RS; McMillan KR; Flood-Urdangarin C; Harvey SB; Wilson-Grady JT; Nelsestuen GL
Int J Obes (Lond); 2007 Aug; 31(8):1334-6. PubMed ID: 17310220
[TBL] [Abstract][Full Text] [Related]
3. APOC1 T45S polymorphism is associated with reduced obesity indices and lower plasma concentrations of leptin and apolipoprotein C-I in aboriginal Canadians.
Lahiry P; Cao H; Ban MR; Pollex RL; Mamakeesick M; Zinman B; Harris SB; Hanley AJ; Huff MW; Connelly PW; Hegele RA
J Lipid Res; 2010 Apr; 51(4):843-8. PubMed ID: 19812053
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein C1: Its Pleiotropic Effects in Lipid Metabolism and Beyond.
Fuior EV; Gafencu AV
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31779116
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Potential Protein Biomarkers for Major Depressive Disorder Using Matrix-Assisted Laser Desorption Ionization/Time-of-Flight Mass Spectrometry.
Lin CH; Su H; Hung CC; Lane HY; Shiea J
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361610
[TBL] [Abstract][Full Text] [Related]
6. Assessment of ApoC1, LuzP6, C12orf75 and OCC-1 in cystic glioblastoma using MALDI-TOF mass spectrometry, immunohistochemistry and qRT-PCR.
Evangelou P; Groll M; Oppermann H; Gaunitz F; Eisenlöffel C; Müller W; Eschrich K; Schänzer A; Nestler U
Med Mol Morphol; 2019 Dec; 52(4):217-225. PubMed ID: 31006040
[TBL] [Abstract][Full Text] [Related]
7. Analysis of metabolic syndrome components in >15 000 african americans identifies pleiotropic variants: results from the population architecture using genomics and epidemiology study.
Carty CL; Bhattacharjee S; Haessler J; Cheng I; Hindorff LA; Aroda V; Carlson CS; Hsu CN; Wilkens L; Liu S; Selvin E; Jackson R; North KE; Peters U; Pankow JS; Chatterjee N; Kooperberg C
Circ Cardiovasc Genet; 2014 Aug; 7(4):505-13. PubMed ID: 25023634
[TBL] [Abstract][Full Text] [Related]
8. Reduced very-low-density lipoprotein fractional catabolic rate in apolipoprotein C1-deficient mice.
Jong MC; van Ree JH; Dahlmans VE; Frants RR; Hofker MH; Havekes LM
Biochem J; 1997 Jan; 321 ( Pt 2)(Pt 2):445-50. PubMed ID: 9020879
[TBL] [Abstract][Full Text] [Related]
9. Association between APOC1 polymorphism and Alzheimer's disease: a case-control study and meta-analysis.
Zhou Q; Zhao F; Lv ZP; Zheng CG; Zheng WD; Sun L; Wang NN; Pang S; de Andrade FM; Fu M; He XH; Hui J; Jiang W; Yang CY; Shi XH; Zhu XQ; Pang GF; Yang YG; Xie HQ; Zhang WD; Hu CY; Yang Z
PLoS One; 2014; 9(1):e87017. PubMed ID: 24498013
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E-C1-C4-C2 gene cluster region and inter-individual variation in plasma lipoprotein levels: a comprehensive genetic association study in two ethnic groups.
Pirim D; Radwan ZH; Wang X; Niemsiri V; Hokanson JE; Hamman RF; Feingold E; Bunker CH; Demirci FY; Kamboh MI
PLoS One; 2019; 14(3):e0214060. PubMed ID: 30913229
[TBL] [Abstract][Full Text] [Related]
11. Reversal of hyperlipidaemia in apolipoprotein C1 transgenic mice by adenovirus-mediated gene delivery of the low-density-lipoprotein receptor, but not by the very-low-density-lipoprotein receptor.
Jong MC; van Dijk KW; Dahlmans VE; Van der Boom H; Kobayashi K; Oka K; Siest G; Chan L; Hofker MH; Havekes LM
Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):281-7. PubMed ID: 10024503
[TBL] [Abstract][Full Text] [Related]
12. In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.
Jong MC; Dahlmans VE; van Gorp PJ; van Dijk KW; Breuer ML; Hofker MH; Havekes LM
J Clin Invest; 1996 Nov; 98(10):2259-67. PubMed ID: 8941642
[TBL] [Abstract][Full Text] [Related]
13. ApoE and ApoC-I polymorphisms: association of genotype with cardiovascular disease phenotype in African Americans.
Anuurad E; Yamasaki M; Shachter N; Pearson TA; Berglund L
J Lipid Res; 2009 Jul; 50(7):1472-8. PubMed ID: 19252179
[TBL] [Abstract][Full Text] [Related]
14. APOE genotypes in African American female multiple sclerosis patients.
Huang R; Hughes M; Mobley S; Lanham I; Poduslo SE
Neurosci Lett; 2007 Feb; 414(1):51-6. PubMed ID: 17254710
[TBL] [Abstract][Full Text] [Related]
15. Mass spectral study of polymorphism of the apolipoproteins of very low density lipoprotein.
Bondarenko PV; Cockrill SL; Watkins LK; Cruzado ID; Macfarlane RD
J Lipid Res; 1999 Mar; 40(3):543-55. PubMed ID: 10064743
[TBL] [Abstract][Full Text] [Related]
16. Isoforms of apolipoprotein C-I associated with individuals with coronary artery disease.
Moore D; McNeal C; Macfarlane R
Biochem Biophys Res Commun; 2011 Jan; 404(4):1034-8. PubMed ID: 21187063
[TBL] [Abstract][Full Text] [Related]
17. Oxidized ApoC1 on MALDI-TOF and glycated-ApoA1 band on gradient gel as potential diagnostic tools for atherosclerotic vascular disease.
Chang CT; Liao HY; Chang CM; Chen CY; Chen CH; Yang CY; Tsai FJ; Chen CJ
Clin Chim Acta; 2013 May; 420():69-75. PubMed ID: 23078847
[TBL] [Abstract][Full Text] [Related]
18. Both lipolysis and hepatic uptake of VLDL are impaired in transgenic mice coexpressing human apolipoprotein E*3Leiden and human apolipoprotein C1.
Jong MC; Dahlmans VE; van Gorp PJ; Breuer ML; Mol MJ; van der Zee A; Frants RR; Hofker MH; Havekes LM
Arterioscler Thromb Vasc Biol; 1996 Aug; 16(8):934-40. PubMed ID: 8696956
[TBL] [Abstract][Full Text] [Related]
19. Acrolein modification impairs key functional features of rat apolipoprotein E: identification of modified sites by mass spectrometry.
Tran TN; Kosaraju MG; Tamamizu-Kato S; Akintunde O; Zheng Y; Bielicki JK; Pinkerton K; Uchida K; Lee YY; Narayanaswami V
Biochemistry; 2014 Jan; 53(2):361-75. PubMed ID: 24325674
[TBL] [Abstract][Full Text] [Related]
20. Human apolipoprotein C1 transgenesis reduces atherogenesis in hypercholesterolemic rabbits.
Gautier T; Deckert V; Aires V; Le Guern N; Proukhnitzky L; Patoli D; Lemaire S; Maquart G; Bataille A; Xolin M; Magnani C; Masson D; Harscoët E; Da Silva B; Houdebine LM; Jolivet G; Lagrost L
Atherosclerosis; 2021 Mar; 320():10-18. PubMed ID: 33497863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
